TO STUDY THE EFFECT OF MATERNAL FACTORS ON MORTALITY OF VERY LOW BIRTH WEIGHT NEONATES

Authors

  • ANITA HARINKHEDE Department of Pediatrics, CIMS, Chhindwara, Madhya Pradesh, India.
  • DEEPAK KUMAR PATEL Department of Pediatrics, CIMS, Chhindwara, Madhya Pradesh, India.
  • JYOTI NAGWANSHI Depatment of Medicine, CIMS, Chhindwara, Madhya Pradesh, India.
  • AMIT RAHANGDALE Department of Orthopaedics, CIMS, Chhindwara, Madhya Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i11.49526

Keywords:

Neonatal mortality, Maternal risk factors, ACS, VLBW

Abstract

Objectives: The present study is to determine the influences of maternal risk factors on neonatal mortality in very low birth weight (VLBW) infants born in central India.

Methods: A nested case–control study was conducted in the prospectively assembled cohort at the Department of Pediatrics Government Medical College and Hospital, Nagpur, India, for 2 years. Intramural neonates admitted to NICU with a birth weight of 500–1500 g were included in the study. Newborns with major congenital malformation and those who died in the delivery room or within 12 h of birth were excluded from the study.

Results: A total of 260 inborn VLBW newborns admitted to the NICU were enrolled. The mean gestational age was 33.58±4.8 weeks, and the mean birth weight was 1256.56±182.8 g. The overall case fatality rate was 50.38%. Maternal body mass index (BMI) <18.5 g/m2 (p=0.0019 [(Odds Ratio [OR]=3.23) (95% confidence interval [CI]. 1.43–7.80)]) and ante partum hemorrhage (p=0.0001[(OR=3.57) (95% CI 1.82–7.22)]) were two maternal factors which significantly increased the risk of death. However, antenatal steroid coverage (p=0.0005 [(OR=2.25) (95% CI 1.12–5.35)]) was associated with improved survival of VLBW neonates.

Conclusion: It can be said that very low birth neonates, especially those weighing <1000 g, preterm, and who are critically ill due to disturbance in pulmonary and circulatory physiology have a very high risk of mortality. Low maternal BMI and antepartum hemorrhage in mothers of VLBW neonate were associated with increased neonatal mortality and ACS therapy was associated with decreased neonatal mortality.

Downloads

Download data is not yet available.

References

Sankar MJ, Neogi SB, Sharma J, Chauhan M, Srivastava R, Prabhakar PK, et al. State of newborn health in India. J Perinatol 2016;36:S3-8. doi: 10.1038/jp.2016.183, PMID 27924104

Ilyes SG, Chiriac VD, Gluhovschi A, Mihaela V, Dahma G, Mocanu AG, et al. The influence of maternal factors on Neonatal Intensive Care Unit admission and in-hospital mortality in premature newborns from Western Romania: A population-based study. Medicina (Kaunas) 2022;58:709. doi: 10.3390/medicina58060709, PMID 35743972

Zupan J, Aahman E. Perinatal Mortality for the Year 2000: Estimates Developed by WHO. Geneva: WHO; 2005.

Basu S, Rathore P, Bhatia BD. Predictors of mortality in very low birth weight neonates in India. Singapore Med J 2008;49:556-60. PMID 18695864

Gera T, Ramji S. Early predictors of mortality in very low birth weight neonates. Indian Pediatr 2001;38:596-602. PMID 11418725

Almeida CJ, Mendes VM, Carvalho RT, Prates CA. Risk factors for the mortality of very low birth weight newborns at a Neonatal Intensive Care Unit. Rev Paul Pediatr 2012;30:369-76. doi: 10.1590/S0103- 05822012000300010

Devi Meenakshi K, Seeralar AS, Padmanaban S. Clinical profile and factors determining outcome of intramural very low birth weight babies in a tertiary care centre: A retrospective study. Int J Res Med Sci 2017;5:520-4. doi: 10.18203/2320-6012.ijrms20170143

Wang Y, Tseng H, Yang S, Lu C, Wu J, Dai Z, et al. Effects of antenatal corticosteroids on neonatal outcomes in very-low-birth-weight preterm newborns: A 10-year retrospective study in a medical center. Pediatr Neonatol 2012;53:178-83. doi: 10.1016/j.pedneo.2012.04.004

Published

07-11-2023

How to Cite

HARINKHEDE, A., D. KUMAR PATEL, J. NAGWANSHI, and A. RAHANGDALE. “TO STUDY THE EFFECT OF MATERNAL FACTORS ON MORTALITY OF VERY LOW BIRTH WEIGHT NEONATES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 11, Nov. 2023, pp. 147-9, doi:10.22159/ajpcr.2023.v16i11.49526.

Issue

Section

Original Article(s)